Study of LYL314 in Aggressive Large B-Cell Lymphoma
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
National Institutes of Health Clinical Center (CC)
Kelonia Therapeutics, Inc.
University Health Network, Toronto
Cogent Biosciences, Inc.
Novartis
Shenzhen University General Hospital
University Hospital Muenster
AO GENERIUM
Swiss Pediatric Oncology Group